...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

"Bear - I assume that Dr. Cummings is referring to diabetics only since all trial sub study patients are diabetics?"

I think you answered your own question. BETonMACE is all diabetic patients.

"I agree that for him to say ‘very promising’ is strong language, but coming from a medical professional of his stature do you think that is somewhat equivalent to a ‘wow’ in layman’s terms?"

I am interpreting today's news release like a successful top-line news announcement of MoCA score change in the cognition sub-study. Just my opinion, but this sounds like a winner.

BDAZ

Share
New Message
Please login to post a reply